BioSig Technologies Signs a New Licensing Agreement with Mayo Clinic

New Agreement to Support Development of Advanced Features of PURE EP™ System Westport, CT, Sept. 12, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical technology company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, today announced that it signed a new licensing agreement with Mayo Clinic.  The new agreement aims to develop a new product pipeline to support some of the…